Table IV.
CVD risk factors | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Age (years) | Systolic BP ≥ 95th percentile | Diastolic (K5) BP ≥ 95th percentile | Total cholesterol > 200 mg/dL | LDL > 130 mg/dL | HDL < 50 mg/dL | Triglycerides ≥ 130 mg/dL | ||||||
OW | ~OW | OW | ~OW | OW | ~OW | OW | ~OW | OW | ~OW | OW | ~OW | |
9 | 7% | 1% | 4% | 2% | 14% | 16% | 21% | 17% | 4% | 4% | 9% | 5% |
10 | 6% | 2% | 3% | 1% | 14% | 13% | 20% | 15% | 13% | 4% | 20% | 7% |
11 | 9% | 2% | 3% | 1% | 8% | 10% | 14% | 8% | 6% | 2% | 17% | 9% |
12 | 9% | 2% | 2% | 1% | 8% | 9% | 11% | 8% | 6% | 3% | 16% | 9% |
13 | 10% | 2% | 4% | 1% | 10% | 6% | 12% | 6% | 6% | 1% | 18% | 8% |
14 | 7% | 2% | 3% | 1% | 8% | 6% | 9% | 5% | 3% | 1% | 15% | 5% |
15 | 6% | 1% | 4% | 1% | 12% | 8% | 16% | 7% | 7% | 1% | 13% | 6% |
16 | 5% | 1% | 4% | 2% | 8% | 9% | 14% | 8% | 3% | 1% | 14% | 6% |
17 | 4% | 1% | 5% | 2% | * | * | * | * | * | * | * | * |
18 | 5% | 1% | 6% | 1% | 21% | 10% | 28% | 9% | 5% | 1% | 21% | 8% |
| ||||||||||||
OR (CI) ‡ | 10.0 (5.0-20.0), | 3.0 (1.3-7.3), p=0.01 | 1.2 (0.4-3.1), p=0.77 | 2.4 (0.9-6.0), p=0.07 | 6.3 (3.4-11.8), | 3.3 (1.6-7.1), p=0.002 | ||||||
| ||||||||||||
OR (CI) § | 1.5 (0.6-3.6), p=0.37 | 3.0 (1.3-7.0), p=0.01 | 5.4 (2.8-10.3), p<0.001 | 5.0 (2.3-10.8), p<0.001 |
Data not shown for lipids at age 17, due to small sample size (≤ 73).
These odds ratios are for models controlling for maturation stage in addition to age. This was done for lipids, based on past work indicating that maturation is associated with lipid levels.
Odds ratio (95% confidence interval) in models adjusting for age but not maturation stage.
Odds ratio (95% confidence interval) in models adjusting for maturation stage as well as age (lipids only, based on hypothesis).